HAEM5:Essential thrombocythaemia: Difference between revisions
| [checked revision] | [checked revision] |
Bailey.Glen (talk | contribs) Removed old template contents |
Bailey.Glen (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
{{DISPLAYTITLE:Essential thrombocythaemia}} | {{DISPLAYTITLE:Essential thrombocythaemia}} | ||
[[HAEM5:Table_of_Contents|Haematolymphoid Tumours (WHO Classification, 5th ed.)]] | [[HAEM5:Table_of_Contents|Haematolymphoid Tumours (WHO Classification, 5th ed.)]] | ||
| Line 13: | Line 12: | ||
Rebecca Smith, PhD, Director, Genetics Associates, Nashville, TN | Rebecca Smith, PhD, Director, Genetics Associates, Nashville, TN | ||
==WHO Classification of Disease== | ==WHO Classification of Disease== | ||